Periodontal disease and dental caries are associated with an increased risk for ischemic stroke and major adverse cardiovascular events.
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced interim safety ...
Sonoma Biotherapeutics has announced positive interim results from its ongoing phase 1 Regulate-RA trial evaluating ...
People with gum disease may have higher levels of brain white matter damage, a new study finds. Researchers observed that participants with gum disease had significantly more white matter ...
Kymera Therapeutics recently presented new preclinical data for its oral IRF5 degrader KT-579 at the American College of Rheumatology 2025 meeting, showing disease-modifying activity in lupus and ...
Your mouth's health significantly impacts your entire body, new research reveals. Poor oral hygiene is linked to serious ...
KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro ...
Patients with rheumatoid arthritis-associated lung disease demonstrate a significant increased risk for serious infection vs.
Co-led b y Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and WeatherdenInnovative lead program, ELV001, ...
With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the ...
SEOUL, Oct. 14 (UPI) --South Korea's Hyundai ADM Bio said Tuesday that its new cancer drug under development, Penetrium, also may prove effective treating such diseases as rheumatoid arthritis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback